4.8 Review

Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities

期刊

ADVANCED SCIENCE
卷 7, 期 23, 页码 -

出版社

WILEY
DOI: 10.1002/advs.202002611

关键词

aging; clinical trials; healthspan; senescent cells; senolytics; senotherapy

资金

  1. National Key Research and Development Program of China [2016YFC1302400, 2019YFC2002801]
  2. Strategic Priority Research Program of Chinese Academy of Sciences [XDB39010500]
  3. National Natural Science Foundation of China (NSFC) [81472709, 31671425, 31871380]
  4. Key Lab of Tissue Microenvironment and Tumor of Chinese Academy of Sciences [201506, 201706, 202008]
  5. program of Shanghai Academic/Technology Research Leader of the Science and Technology Commission of Shanghai Municipality [20XD1404300]
  6. Antiaging Collaborative Program of SIBS [C01201911260006]
  7. Antiaging Collaborative Program of BY-HEALTH [C01201911260006]
  8. University and Locality Collaborative Development Program of Yantai [2019XDRHXMRC08]
  9. U.S. Department of Defense (DoD) Prostate Cancer Research Program (PCRP) (Idea Development Award) [PC111703]
  10. U.S. National Institutes of Health [R37-AG013925, P01 AG062413]
  11. Connor Fund
  12. Noaber Foundation

向作者/读者索取更多资源

Aging is a physiological decline in both structural homeostasis and functional integrity, progressively affecting organismal health. A major hallmark of aging is the accumulation of senescent cells, which have entered a state of irreversible cell cycle arrest after experiencing inherent or environmental stresses. Although cellular senescence is essential in several physiological events, it plays a detrimental role in a large array of age-related pathologies. Recent biomedical advances in specifically targeting senescent cells to improve healthy aging, or alternatively, postpone natural aging and age-related diseases, a strategy termed senotherapy, have attracted substantial interest in both scientific and medical communities. Challenges for aging research are highlighted and potential avenues that can be leveraged for therapeutic interventions to control aging and age-related disorders in the current era of precision medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据